Kelley Shannon T 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Jan 20, 2026
Insider Transaction Report
Form 4
Kelley Shannon T
General Counsel
Transactions
- Sale
Common Stock
[F1]2026-01-20$490.77/sh−263$129,073→ 8,910 total - Sale
Common Stock
[F2]2026-01-20$501.40/sh−429$215,101→ 8,481 total
Footnotes (2)
- [F1]This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
- [F2]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024.
Signature
/s/ Mardi Dier, as Attorney-in-Fact|2026-01-20